Search results
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 1 day agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 hours agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Analysts Issue Forecasts for Greif, Inc.’s Q3 2024 Earnings (NYSE:GEF)
ETF DAILY NEWS· 13 hours agoGreif, Inc. (NYSE:GEF – Free Report) – Stock analysts at Zacks Research boosted their Q3 2024 EPS...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
F5, Inc. (NASDAQ:FFIV) Shares Sold by KBC Group NV
ETF DAILY NEWS· 5 hours agoThe fund owned 18,413 shares of the network technology company’sstock after selling 29,363 shares during the period. KBC Group NV’s holdings in F5 were...
Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at Chardan Capital
ETF DAILY NEWS· 12 hours agoCoya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating restated by analysts at Chardan Capital in a report released on Wednesday, Benzinga reports.
Enlight Renewable Energy (NASDAQ:ENLT) Shares Gap Down to $17.73
ETF DAILY NEWS· 8 hours agoShares of Enlight Renewable Energy Ltd (NASDAQ:ENLT – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $17.73, but opened at ...
Zacks Research Weighs in on NMI Holdings, Inc.’s Q1 2025 Earnings (NASDAQ:NMIH)
ETF DAILY NEWS· 12 hours ago(NASDAQ:NMIH – Free Report) – Zacks Research lowered their Q1 2025 earnings estimates for NMI in a note issued to investors on Monday, June 3rd. Zacks Research analyst R. Department now < ...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 11 hours agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
IDACORP, Inc. (NYSE:IDA) Receives $97.40 Average Target Price from Analysts
ETF DAILY NEWS· 12 hours agoFive investment analysts have rated the stock with a hold rating. Wells Fargo & Company lifted their price target on shares of IDACORP from $94.00 to $98.00 and gave the company ...